Second-Generation Antipsychotic Utilization and Metabolic Parameter Monitoring in an Inpatient Pediatric Population: A Retrospective Analysis

Waist Circumference is a Sensitive Screening Tool for Assessment of Metabolic Syndrome Risk in Children Treated with Second-Generation Antipsychotics

(2017) Constadina Panagiotopoulos et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Intensified association between waist circumference and hypertension in abdominally overweight children

(2016) Bin Dong et al.   Obesity Research & Clinical Practice

Treatment of Young People With Antipsychotic Medications in the United States

(2015) Mark Olfson et al.   JAMA Psychiatry

Child and Adolescent Psychiatrists' Attitudes and Practices Prescribing Second Generation Antipsychotics

(2014) Angie Mae Rodday et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

A Brief History of FDA Compounding Oversight

(2013) Stanford T. Shulman   PEDIATRIC ANNALS

National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics

(2012) Mark Olfson et al.   ARCHIVES OF GENERAL PSYCHIATRY

Metabolic Screening in Children Receiving Antipsychotic Drug Treatment

(2012) Elaine H. Morrato et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

The Relationship between Mental Health Diagnosis and Treatment with Second-Generation Antipsychotics over Time: A National Study of U.S. Medicaid-Enrolled Children

(2012) Meredith Matone et al.   HEALTH SERVICES RESEARCH

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION